Dew, thanks so much for that thorough analysis. I was so unhappy with the buyout going forward that I forgot to factor in the LNTH share price decline. So PGNX shareholders get more of LNTH, company worth less than it was, and whose lead product has declining sales and is facing competition. I would have preferred a major dilution to raise cash.
It is also troubling to me that no value has been given to the CVR, which appears to be part of the renegotiated deal as I don't recall it being mentioned before. I owned CLEG when BMY bought it out and BMY had a CVR too, which they stated in the agreement could be worth up to $9 a share. One would think there would be a number attached to the CVR in the PGNX buyout, even as only an estimate.
In any event, I sold off half my shares yesterday, and may sell more or the rest sooner rather than later. I can't be upset as I came out ahead after a long road, just not as much as I had hoped.
Market Data 
Markets 
AI
